legal-news
1:24-cv-00882 Genzyme Corporation v. Sarepta Therapeutics, Inc. et al
24-cv-00882
|
|
Filed
Advertisement
description
Case Summary
Genzyme Corporation initiated litigation against Sarepta Therapeutics, Inc. and others under docket 24-cv-00882. The case involves patent or commercial disputes typical of pharmaceutical companies, but specific details are not provided. Recent procedural notes indicate that motions in the case are no longer referred, suggesting a change in case management or judicial assignment.
Stage
Motion practice
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Pharmaceutical litigation
- • Case management changes
- • Procedural motions
Advertisement
Case Timeline
1 event
info
Motion
April 14, 2026
1:24-cv-00882 Genzyme Corporation v. Sarepta Therapeutics, Inc. et al
In the case between Genzyme Corporation and Sarepta Therapeutics, the court decided that motions will no longer be automatically sent to a magistrate judge for review. This means that the judge assigned to the case will now handle motions directly, potentially speeding up decision-making.
Advertisement
newspaper
1 article